Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Individualizing Corticosteroid Use in Pneumonia
NCT05334316Phase 2Completed
- Sponsor
- Mayo Clinic
- Start
- Nov 2024
- Primary completion
- Apr 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of dexamethasone in community acquired pneumonia (CAP), sponsored by Mayo Clinic. Started Nov 2024; status: completed.
02
Drugs
dexamethasone
03
Conditions
community acquired pneumonia (CAP)
Beyond the preview
Go deeper on NCT05334316.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05334316.